Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

2 results
Display

Transcatheter Arterial Chemotherapy with Miriplatin for Hepatocellular Carcinoma Patients with Chronic Renal Failure: Report of Three Cases

Imai N, Ikeda K, Seko Y, Kawamura Y, Sezaki H, Hosaka T, Akuta N, Kobayashi , Saitoh S, Suzuki F, Suzuki Y, Arase Y, Kumada H

  • KMID: 2135078
  • Gut Liver.
  • 2013 Mar;7(2):246-251.
Miriplatin is a novel lipophilic platinum complex that was developed to treat hepatocellular carcinoma (HCC). Although HCC patients frequently have coexisting chronic renal failure, little prospective data are available regarding...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
What Is the Most Effective Drug Delivery System for Cisplatin during the Treatment of Hepatic Tumors with Single-Session Transcatheter Chemotherapy? A Pilot Study

Kawamura Y, Ikeda K, Fukushima , Seko Y, Hara T, Sezaki H, Hosaka T, Akuta N, Kobayashi , Saitoh S, Suzuki F, Suzuki Y, Arase Y, Kumada H

  • KMID: 1806675
  • Gut Liver.
  • 2013 Sep;7(5):576-584.
BACKGROUND/AIMS: The aim of this study was to determine the pharmacodynamics of cisplatin following three different treatment procedures for intrahepatic arterial infusion therapy for hepatocellular carcinoma (HCC). METHODS: We divided 13...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr